• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CGEM

CGEM

Cullinan Therapeutics, Inc.

NASDAQHealthcareMedical - PharmaceuticalsUS

USD15.21

-0.13 (-0.85%)

Rating:C+

Company Profile

CEO

Nadim Ahmed

IPO Date

2021-01-08

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Exchange

NASDAQ

Country

US

Market Metrics

Open

$15.35

Prev. Close

$15.34

Day Low

$15.01

Day High

$15.46

52W Low

$5.68

52W High

$16.74

Market Cap

$0.93B

Volume

0.78M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

47.5%

Avg Negative

4.8%

Avg Neutral

47.7%

News Feed

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

GlobeNewsWire·8/10/2021·↑ positive

Cullinan (CGEM) Rises on Promising Phase I Cancer Study Data

Zacks Investment Research·6/7/2021·↑ positive

Why Cullinan Oncology Stock Is Skyrocketing Today

The Motley Fool·6/4/2021·↑ positive

Cullinan Oncology Announces Management Transition

GlobeNewsWire·5/21/2021·↓ negative

Cullinan Oncology to Provide CLN-081 Clinical Update at ASCO 2021

GlobeNewsWire·5/19/2021·↑ positive

Cullinan Oncology Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/14/2021·↑ positive

Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/7/2021·↑ positive

Cullinan Oncology Reports Full Year 2020 Financial Results and Business Highlights

GlobeNewsWire·3/30/2021·↑ positive

Cullinan Management, Inc. Announces Business Update

GlobeNewsWire·2/22/2021·↓ negative

Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·1/12/2021·↑ positive